Order Article Reprints

Wharton L, McNeil SW, Merkens H, Yuan Z, Van de Voorde M, Engudar G, Ingham A, Koniar H, Rodríguez-Rodríguez C, Radchenko V, et al. Preclinical Evaluation of [^155/161Tb]Tb-Crown-TATE—A Novel SPECT Imaging Theranostic Agent Targeting Neuroendocrine Tumours. Molecules. 2023; 28(7):3155. https://doi.org/10.3390/molecules28073155

Wharton, Luke, Scott W. McNeil, Helen Merkens, Zheliang Yuan, Michiel Van de Voorde, Gokce Engudar, Aidan Ingham, Helena Koniar, Cristina Rodríguez-Rodríguez, Valery Radchenko, and et al. 2023. "Preclinical Evaluation of [^155/161Tb]Tb-Crown-TATE—A Novel SPECT Imaging Theranostic Agent Targeting Neuroendocrine Tumours" Molecules 28, no. 7: 3155. https://doi.org/10.3390/molecules28073155

Wharton, L., McNeil, S. W., Merkens, H., Yuan, Z., Van de Voorde, M., Engudar, G., Ingham, A., Koniar, H., Rodríguez-Rodríguez, C., Radchenko, V., Ooms, M., Kunz, P., Bénard, F., Schaffer, P., & Yang, H. (2023). Preclinical Evaluation of [^155/161Tb]Tb-Crown-TATE—A Novel SPECT Imaging Theranostic Agent Targeting Neuroendocrine Tumours. Molecules, 28(7), 3155. https://doi.org/10.3390/molecules28073155